E. Noiri et al., IN-VIVO TARGETING OF INDUCIBLE NO SYNTHASE WITH OLIGODEOXYNUCLEOTIDESPROTECTS RAT-KIDNEY AGAINST ISCHEMIA, The Journal of clinical investigation, 97(10), 1996, pp. 2377-2383
Gene products of all three distinct nitric oxide synthases are present
in the mammalian kidney, This mosaic topography of nitric oxide synth
ase (NOS) isoforms probably reflects distinct functional role played b
y each enzyme. While nitric oxide (NO) is cytotoxic to isolated renal
tubules, inhibition of NO production in vivo invariably results in the
aggravation of renal dysfunction in various models of acute renal fai
lure. We reasoned that the existing ambiguity on the role of nitric ox
ide in acute renal failure is in part due to the lack of selective NOS
inhibitors. Phosphorothioated derivatives of antisense oligodeoxynucl
eotides targeting a conserved sequence within the open reading frame o
f the cDNA encoding the inducible NOS (iNOS) were designed to produce
a selective knock-down of this enzyme, In vivo use of these antisense
constructs attenuated acute rend failure in rats subjected to renal is
chemia. This effect was due, at least in part, to the rescue of tubula
r epithelium from lethal injury, Application of antisense constructs d
id not affect endothelial NOS, as evidenced by a spared NO release aft
er the infusion of bradykinin during in vivo monitoring with an NO-sel
ective microelectrode. In conclusion, the data provide direct evidence
for the cytotoxic effects of NO produced via iNOS in the course of is
chemic acute renal failure, and offer a novel method to selectively pr
event the induction of this enzyme. (J. Clin. Invest. 1996. 97:2377-23
83.)